Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Should You Invest in Ozempic Maker Novo Nordisk in 2026?
01:22pm, Friday, 26'th Dec 2025
The FDA has approved a daily Wegovy pill. The new version of the weight loss drug will hit the market next month.
GLP-1 Drugs Quietly Reshape How Americans Shop for Food, Study Finds
12:05pm, Friday, 26'th Dec 2025
Weight loss may be just one side effect of GLP-1 drugs. A new study suggests they're also changing how consumers spend on food.Researchers at Cornell University
Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access
08:01am, Friday, 26'th Dec 2025
Weight-loss drugs known as GLP-1s are increasingly reshaping healthcare and the pharmaceutical landscape, with Eli Lilly (LLY) and Novo Nordisk (NVO) emerging a
First Look: Stocks Hit Records; Nvidia-Groq, Novo Pill
07:38am, Thursday, 25'th Dec 2025
Stock News Arkansas ticket wins $1.817B Powerball: A single ticket sold in Arkansas matched all numbers for the $1.817 billion Powerball jackpot, the second-lar
ARS Investment Partners LLC Has $8.54 Million Stake in Novo Nordisk A/S $NVO
03:19am, Thursday, 25'th Dec 2025
ARS Investment Partners LLC grew its stake in Novo Nordisk A/S (NYSE: NVO) by 69.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange C
Novo Nordisk (NVO) Rises Higher Than Market: Key Facts
06:46pm, Wednesday, 24'th Dec 2025
Novo Nordisk (NVO) closed at $52.56 in the latest trading session, marking a +1.84% move from the prior day.
Market Today: Records, BP--Castrol deal, Wegovy pill OK
05:35pm, Wednesday, 24'th Dec 2025
Stock News Dow and S&P 500 close at records: The S&P 500 and Dow Jones notched fresh closing highs in a holiday-shortened session, with leadership from megacaps
NVO's First Oral Obesity Pill Approval: What Does it Mean for Lilly?
11:51am, Wednesday, 24'th Dec 2025
NVO secures FDA approval for its first oral obesity pill, Wegovy, giving it a first-to-market edge and raising questions about Lilly's next move.
Novo Nordisk: The Real Comeback Starts Now With The Wegovy Pill
11:45am, Wednesday, 24'th Dec 2025
Novo Nordisk has finally received FDA approval for the Wegovy pill, aiming to regain ground in the obesity drugs market against Eli Lilly. NVO trades close to a 10-year low forward EBITDA multiple of
NVO Weight-Loss Pill Approved
10:00am, Wednesday, 24'th Dec 2025
2026 could see an explosion in weight loss drug use in the U.S. after the FDA approved NovoNordisk's(NVO) Wegovy pill. Nicole Petallides has the latest from the health care space ======== Schwab Netwo
Stock Market Live December 24, 2025: S&P 500 (SPY) at Record Highs
09:47am, Wednesday, 24'th Dec 2025
Live Updates Americans are in record debt heading into 2026 57 minutes ago Live Household debt exploded to $18.6 trillion during the third quarter of 2025. Of that, $13.07 trillion was in mortgage deb
GLP-1 weight-loss pills set to reshape US food demand in 2026
09:21am, Wednesday, 24'th Dec 2025
Analysts predict packaged food manufacturers and fast-food eateries may be pushed to alter more of their goods next year when newly licensed appetite-suppressing GLP-1 tablets become accessible in Jan
First Look: GDP Surges, S&P Record; BP, Novo Nordisk in Focus
07:38am, Wednesday, 24'th Dec 2025
Stock News U.S. growth accelerates: U.S. GDP expanded at a 4.3% annualized pace in Q3, driven by consumer spending and net exports, though economists expect sof
DAVENPORT & Co LLC Has $146.64 Million Stake in Novo Nordisk A/S $NVO
05:38am, Wednesday, 24'th Dec 2025
DAVENPORT and Co LLC increased its stake in shares of Novo Nordisk A/S (NYSE: NVO) by 54.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm
Exchange Traded Concepts LLC Boosts Stock Position in Novo Nordisk A/S $NVO
04:09am, Wednesday, 24'th Dec 2025
Exchange Traded Concepts LLC lifted its stake in Novo Nordisk A/S (NYSE: NVO) by 22.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange
